ArticleMedComm2024

Interleukin-33 increases the sensitivity of multiple myeloma cells to the proteasome inhibitor bortezomib through reactive oxygen species-mediated inhibition of nuclear factor kappa-B signal and stemness properties.

Ruonan Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.